vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $140.7M, roughly 1.1× Purple Innovation, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs -2.3%, a 10.1% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-7.8M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 8.3%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
NUTX vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $140.7M |
| Net Profit | $11.8M | $-3.2M |
| Gross Margin | 30.4% | 41.9% |
| Operating Margin | 20.4% | -1.6% |
| Net Margin | 7.8% | -2.3% |
| Revenue YoY | -41.1% | 9.1% |
| Net Profit YoY | -80.8% | 62.1% |
| EPS (diluted) | $2.34 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $140.7M | ||
| Q3 25 | $267.8M | $118.8M | ||
| Q2 25 | $244.0M | $105.1M | ||
| Q1 25 | $211.8M | $104.2M | ||
| Q4 24 | $257.6M | $129.0M | ||
| Q3 24 | $78.8M | $118.6M | ||
| Q2 24 | $76.1M | $120.3M | ||
| Q1 24 | $67.5M | $120.0M |
| Q4 25 | $11.8M | $-3.2M | ||
| Q3 25 | $55.4M | $-11.7M | ||
| Q2 25 | $-17.7M | $-17.3M | ||
| Q1 25 | $21.2M | $-19.1M | ||
| Q4 24 | $61.6M | $-8.5M | ||
| Q3 24 | $-8.8M | $-39.2M | ||
| Q2 24 | $-364.0K | $27.0K | ||
| Q1 24 | $-364.0K | $-50.2M |
| Q4 25 | 30.4% | 41.9% | ||
| Q3 25 | 57.8% | 42.8% | ||
| Q2 25 | 51.2% | 35.9% | ||
| Q1 25 | 55.9% | 39.4% | ||
| Q4 24 | 55.0% | 42.9% | ||
| Q3 24 | 27.8% | 29.7% | ||
| Q2 24 | 29.7% | 40.7% | ||
| Q1 24 | 15.1% | 34.8% |
| Q4 25 | 20.4% | -1.6% | ||
| Q3 25 | 48.7% | -10.2% | ||
| Q2 25 | 13.8% | -13.5% | ||
| Q1 25 | 38.1% | -13.9% | ||
| Q4 24 | 44.4% | -6.0% | ||
| Q3 24 | 12.3% | -39.5% | ||
| Q2 24 | 7.0% | -12.1% | ||
| Q1 24 | 2.1% | -19.3% |
| Q4 25 | 7.8% | -2.3% | ||
| Q3 25 | 20.7% | -9.9% | ||
| Q2 25 | -7.3% | -16.5% | ||
| Q1 25 | 10.0% | -18.4% | ||
| Q4 24 | 23.9% | -6.6% | ||
| Q3 24 | -11.2% | -33.1% | ||
| Q2 24 | -0.5% | 0.0% | ||
| Q1 24 | -0.5% | -41.8% |
| Q4 25 | $2.34 | $0.03 | ||
| Q3 25 | $7.76 | $0.11 | ||
| Q2 25 | $-2.95 | $0.16 | ||
| Q1 25 | $3.33 | $0.18 | ||
| Q4 24 | $11.56 | $0.08 | ||
| Q3 24 | $-1.72 | $0.36 | ||
| Q2 24 | $-0.07 | $0.00 | ||
| Q1 24 | $-0.08 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $329.4M | $-29.7M |
| Total Assets | $918.5M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $24.3M | ||
| Q3 25 | $166.0M | $32.4M | ||
| Q2 25 | $96.7M | $34.2M | ||
| Q1 25 | $84.7M | $21.6M | ||
| Q4 24 | $40.6M | $29.0M | ||
| Q3 24 | $46.9M | $23.4M | ||
| Q2 24 | $40.8M | $23.4M | ||
| Q1 24 | $30.0M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $329.4M | $-29.7M | ||
| Q3 25 | $317.2M | $-26.9M | ||
| Q2 25 | $235.3M | $-15.6M | ||
| Q1 25 | $176.9M | $1.3M | ||
| Q4 24 | $132.4M | $20.2M | ||
| Q3 24 | $60.4M | $28.0M | ||
| Q2 24 | $62.7M | $66.4M | ||
| Q1 24 | $63.0M | $65.5M |
| Q4 25 | $918.5M | $296.3M | ||
| Q3 25 | $964.5M | $302.1M | ||
| Q2 25 | $841.0M | $303.8M | ||
| Q1 25 | $761.9M | $293.8M | ||
| Q4 24 | $655.3M | $307.8M | ||
| Q3 24 | $438.5M | $309.3M | ||
| Q2 24 | $422.4M | $362.1M | ||
| Q1 24 | $404.3M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $-5.8M |
| Free Cash FlowOCF − Capex | $69.0M | $-7.8M |
| FCF MarginFCF / Revenue | 45.5% | -5.5% |
| Capex IntensityCapex / Revenue | 0.9% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $-5.8M | ||
| Q3 25 | $99.5M | $-968.0K | ||
| Q2 25 | $27.3M | $-4.0M | ||
| Q1 25 | $51.0M | $-23.1M | ||
| Q4 24 | $54.0K | $6.8M | ||
| Q3 24 | $6.8M | $1.1M | ||
| Q2 24 | $13.3M | $-8.9M | ||
| Q1 24 | $3.1M | $-16.8M |
| Q4 25 | $69.0M | $-7.8M | ||
| Q3 25 | $99.2M | $-1.8M | ||
| Q2 25 | $26.5M | $-7.0M | ||
| Q1 25 | $50.9M | $-25.3M | ||
| Q4 24 | $-341.0K | $5.7M | ||
| Q3 24 | $6.2M | $101.0K | ||
| Q2 24 | $12.7M | $-11.0M | ||
| Q1 24 | $2.3M | $-19.9M |
| Q4 25 | 45.5% | -5.5% | ||
| Q3 25 | 37.0% | -1.5% | ||
| Q2 25 | 10.9% | -6.6% | ||
| Q1 25 | 24.0% | -24.3% | ||
| Q4 24 | -0.1% | 4.4% | ||
| Q3 24 | 7.8% | 0.1% | ||
| Q2 24 | 16.7% | -9.2% | ||
| Q1 24 | 3.4% | -16.5% |
| Q4 25 | 0.9% | 1.4% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.3% | 2.8% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | 0.2% | 0.8% | ||
| Q3 24 | 0.8% | 0.9% | ||
| Q2 24 | 0.7% | 1.7% | ||
| Q1 24 | 1.1% | 2.5% |
| Q4 25 | 5.95× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
